Anlon Healthcare IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹86 – ₹91
Lot size
164 shares
Offer application amount
₹14,924
Issue size
₹121.03 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 26 Aug 2025 |
| Close date | 29 Aug 2025 |
| Reported listing date | 3 Sept 2025 |
Issue size
About Anlon Healthcare
Anlon Healthcare Limited, founded in 2013, is one of the growing chemical manufacturing companies engaged in the manufacturing of 2 things: 1. high purity advanced pharmaceutical intermediates used as raw materials for making active pharmaceutical ingredients (APIs). 2. APIs are used in medicines like tablets, capsules, ointments, syrups, as well as in nutraceuticals, personal care, and animal health products. Its portfolio consists of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), nutraceutical APIs, and ingredients for personal care and veterinary use.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.